@WHO: As the latest data show, monoclonal antibodies sotrovimab and casirivimab-imdevimab do not seem to be effective against circulating variants, including Omicron. They should not be used to treat #COVID19. https://t.co/TWKxRYhePK

http://twitter.com/WHO
via IFTTT